Fig. 6
From: Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma
a The expression of Ki-67 in Group 1–8. b, c Ki-67 and TUNEL stained images of mouse tumor tissue after administration of Group 1–8. Scale bar = 60 μm. Group 1–8 correspond to the DOX-CB@lipo-iRGD-in situ-N (+) group, the DOX-CB@lipo-pDNA-iRGD-in situ-N (+) group, the DOX-CB@lipo-iRGD-iv-N (+) group, the lipo-pDNA-iRGD-in situ-N (+) group, the DOX + CB@lipo-iRGD-iv-N (+) group, the BSH-N (+), the N (+) group, and the N (−) group